Breaking News
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free
Close

Biogen Inc (BIIB)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Biogen's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
261.69 -5.76    -2.15%
05/10 - Closed. Currency in USD ( Disclaimer )
After Hours
261.69
-0.00
-0.00%
19:58:50 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 1,562,008
  • Bid/Ask: 257.00 / 267.97
  • Day's Range: 257.51 - 266.43
Biogen 261.69 -5.76 -2.15%

BIIB Dividends

 
Get information about Biogen dividends and ex-dividend dates. You can find more details by going to one of the sections under this page such as ex-date, dividend and payment date.
No data to display
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BIIB Comments

Write your thoughts about Biogen Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Sancho Ponzi
Sancho Ponzi Oct 04, 2022 3:09AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
lecanemab showed statistically significant results, but the effect seems to be too small to notice for most AD patients..
Shabba Ranks
Shabba Ranks Sep 28, 2022 10:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
heading to $2,000 and a 300 billion market cal
John Marty
John Marty Sep 28, 2022 8:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Bios getting less risky as some have a pile of gold hidden within. BIIB good example. $300/ shr.
Giuseppe Giannachi
Giuseppe Giannachi Sep 28, 2022 4:56AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Stock Split?
Douglas Boggs
Douglas Boggs Sep 28, 2022 4:56AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
No, its up on positive outcome on new Alzheimer’s drug!
Daniel Poulin
Daniel Poulin Sep 27, 2022 8:53PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Etude positive sur lecanemab positive study on lecanemab🤑
Tim Gilbs
TimothyTekno2020 Sep 27, 2022 8:53PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Yes, was published last night on Bloomberg. Mine sold at open today for $283 b/c I wasn't expecting an announcement this year, so had set open order sell on a bounce to $212, and was gonna buy back at $195 on the stock market's next leg lower in a month or few. Having owned BIIB and ESALY (Biogen's Japanese biotech partner on these Alzheimer's treatments), I've been following these drug studies since 2017-18 through a high dollar biotech research publication. Both this and the earlier approved drug both work for a large number of Alzheimer's patient. FDA and Medicare just want patients to realize it won't work for a large portion of Alzheimer's patients. But helping even a sizeable minority to a substantial improvement is better than ANYTHING we have today. It reminds me of AZT during late 1980s to mid 1990s; it wasn't great and had serious flaws, but it still saved lives and was better than any other option, or the early treatments for COVID. Over time, the industry will learn how to improve therapy now that we have something that works for a large number of patients.
Sameer Jain
Sameer Jain Jun 17, 2022 11:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
same named company is also listen in indian market.. Biogen
MIKHAIL KUZNETSOV
MIKHAIL KUZNETSOV Jan 29, 2022 8:27AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Waiting for a breakthrough !A great entry point now , as I think , I bought 220 , I think the rocket is fueled here . Just be smarter , dump on time , otherwise you will become a bag holder
TTM Holdings PE
TTM Holdings PE Dec 29, 2021 6:27PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Samsung!
Ovi Mondol
Ovi Mondol Oct 20, 2021 7:28AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
01708620849
StockExchange NYbrokers
StockExchange NYbrokers Sep 09, 2021 7:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
is better to buy RTX US defense company . don't risk your money in Biogen .
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email